Literature DB >> 12123660

Compensation for loss of ligand activity in surface plasmon resonance experiments.

Raimund J Ober1, E Sally Ward.   

Abstract

The determination of equilibrium binding constants is an important aspect of the analysis of protein-protein interactions. In recent years surface plasmon resonance experiments (e.g., with a BIAcore instrument) have provided a valuable experimental approach to determining such constants. The standard method is based on measuring amounts of analyte bound at equilibrium for different analyte concentrations. During the course of a typical surface plasmon resonance experiment the measured equilibrium levels for a given analyte concentration often decrease. This appears to be due to a loss of activity of the protein coupled to the sensor chip or other phenomena. The loss in signal can lead to an erroneous determination of the equilibrium constant. A data analysis approach is introduced that aims to compensate for the loss of activity so that its influence on the results of the experiments is reduced.

Mesh:

Substances:

Year:  2002        PMID: 12123660     DOI: 10.1006/abio.2002.5716

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  Combined affinity and rate constant distributions of ligand populations from experimental surface binding kinetics and equilibria.

Authors:  Juraj Svitel; Andrea Balbo; Roy A Mariuzza; Noreen R Gonzales; Peter Schuck
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

2.  Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies.

Authors:  Carlos Vaccaro; Roger Bawdon; Sylvia Wanjie; Raimund J Ober; E Sally Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

3.  Probing the functional heterogeneity of surface binding sites by analysis of experimental binding traces and the effect of mass transport limitation.

Authors:  Juraj Svitel; Hacène Boukari; Donald Van Ryk; Richard C Willson; Peter Schuck
Journal:  Biophys J       Date:  2006-12-08       Impact factor: 4.033

4.  A comparison of binding surfaces for SPR biosensing using an antibody-antigen system and affinity distribution analysis.

Authors:  Huaying Zhao; Inna I Gorshkova; Gregory L Fu; Peter Schuck
Journal:  Methods       Date:  2012-12-24       Impact factor: 3.608

5.  Targeting Phosphatidylserine with Calcium-Dependent Protein-Drug Conjugates for the Treatment of Cancer.

Authors:  Ran Li; Srinivas Chiguru; Li Li; Dongyoung Kim; Ramraj Velmurugan; David Kim; Siva Charan Devanaboyina; Hong Tian; Alan Schroit; Ralph P Mason; Raimund J Ober; E Sally Ward
Journal:  Mol Cancer Ther       Date:  2017-09-22       Impact factor: 6.261

6.  Engineering a HER2-specific antibody-drug conjugate to increase lysosomal delivery and therapeutic efficacy.

Authors:  Jeffrey C Kang; Wei Sun; Priyanka Khare; Mostafa Karimi; Xiaoli Wang; Yang Shen; Raimund J Ober; E Sally Ward
Journal:  Nat Biotechnol       Date:  2019-04-01       Impact factor: 54.908

7.  Engineered clearing agents for the selective depletion of antigen-specific antibodies.

Authors:  Siva Charan Devanaboyina; Priyanka Khare; Dilip K Challa; Raimund J Ober; E Sally Ward
Journal:  Nat Commun       Date:  2017-05-31       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.